Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2015 (2015), Article ID 565243, 6 pages
http://dx.doi.org/10.1155/2015/565243
Case Report

Hypercalcemia, Anemia, and Acute Kidney Injury: A Rare Presentation of Sarcoidosis

1Department of Medicine, Bronx Lebanon Hospital Center, 1650 Selwyn Avenue, Suite No. 10C, Bronx, NY 10457, USA
2Department of Pathology, Bronx Lebanon Hospital Center, 1650 Grand Concourse, Bronx, NY 10457, USA

Received 18 March 2015; Accepted 14 June 2015

Academic Editor: Jagdish Butany

Copyright © 2015 Neeraj Sharma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Valeyre, A. Prasse, H. Nunes, Y. Uzunhan, P.-Y. Brillet, and J. Müller-Quernheim, “Sarcoidosis,” The Lancet, vol. 383, no. 9923, pp. 1155–1167, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Karnchanasorn, M. Sarikonda, S. Aldasouqi, and V. V. Gossain, “Severe hypercalcemia and acute renal failure: an unusual presentation of sarcoidosis,” Case Reports in Medicine, vol. 2010, Article ID 423659, 5 pages, 2010. View at Publisher · View at Google Scholar
  3. J. S. Adams, “Vitamin D metabolite-mediated hypercalcemia,” Endocrinology and Metabolism Clinics of North America, vol. 18, no. 3, pp. 765–778, 1989. View at Google Scholar · View at Scopus
  4. O. P. Sharma, “Vitamin D, calcium, and sarcoidosis,” Chest, vol. 109, no. 2, pp. 535–539, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. J. S. Adams, F. R. Singer, M. A. Gacad et al., “Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis,” Journal of Clinical Endocrinology and Metabolism, vol. 60, no. 5, pp. 960–966, 1985. View at Publisher · View at Google Scholar · View at Scopus
  6. H. J. Zeimer, T. M. Greenaway, J. Slavin et al., “Parathyroid-hormone-related protein in sarcoidosis,” The American Journal of Pathology, vol. 152, no. 1, pp. 17–21, 1998. View at Google Scholar · View at Scopus
  7. R. P. Baughman, A. S. Teirstein, M. A. Judson et al., “Clinical characteristics of patients in a case control study of sarcoidosis,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 10, pp. 1885–1889, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Boeck, “Multiple benign sarcoid of the skin,” Journal of Cutaneous and Genitourinary Diseases, vol. 17, pp. 543–550, 1899. View at Google Scholar
  9. B. A. Rybicki, M. Major, J. Popovich Jr., M. J. Maliarik, and M. C. Iannuzzi, “Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization,” American Journal of Epidemiology, vol. 145, no. 3, pp. 234–241, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Mirsaeidi, R. F. Machado, D. Schraufnagel, N. J. Sweiss, and R. P. Baughman, “Racial difference in sarcoidosis mortality in the United States,” Chest, vol. 147, no. 2, pp. 438–449, 2015. View at Publisher · View at Google Scholar
  11. P. D. Thomas and G. W. Hunninghake, “Current concepts of the pathogenesis of sarcoidosis,” American Review of Respiratory Disease, vol. 135, no. 3, pp. 747–760, 1987. View at Google Scholar · View at Scopus
  12. R. P. Baughman, D. A. Culver, and M. A. Judson, “A concise review of pulmonary sarcoidosis,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 5, pp. 573–581, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. M. A. Judson, B. W. Thompson, D. L. Rabin et al., “The diagnostic pathway to sarcoidosis,” Chest, vol. 123, no. 2, pp. 406–412, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. A. S. Morgenthau and M. C. Iannuzzi, “Recent advances in sarcoidosis,” Chest, vol. 139, no. 1, pp. 174–182, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. K. A. Fisher, D. M. Serlin, K. C. Wilson, R. E. Walter, J. S. Berman, and H. W. Farber, “Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment,” Chest, vol. 130, no. 5, pp. 1481–1488, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. L. E. Siltzbach, D. G. James, E. Neville et al., “Course and prognosis of sarcoidosis around the world,” The American Journal of Medicine, vol. 57, no. 6, pp. 847–852, 1974. View at Publisher · View at Google Scholar · View at Scopus
  17. J. S. Kim, M. A. Judson, R. Donnino et al., “Cardiac sarcoidosis,” American Heart Journal, vol. 157, no. 1, pp. 9–21, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. M. R. Patel, P. J. Cawley, J. F. Heitner, and et al, “Detection of myocardial damage in patients with sarcoidosis,” Circulation, vol. 120, no. 20, pp. 1969–1977, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Kellinghaus, M. Schilling, and P. Lüdemann, “Neurosarcoidosis: clinical experience and diagnostic pitfalls,” European Neurology, vol. 51, no. 2, pp. 84–88, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. E. E. Lower and K. L. Weiss, “Neurosarcoidosis,” Clinics in Chest Medicine, vol. 29, no. 3, pp. 475–492, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. “Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 2, pp. 736–755, 1999.
  22. H. Yanardaǧ, Ö. N. Pamuk, and G. E. Pamuk, “Lupus pernio in sarcoidosis: clinical features and treatment outcomes of 14 patients,” Journal of Clinical Rheumatology, vol. 9, no. 2, pp. 72–76, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. M. F. Holick, “Vitamin D deficiency,” The New England Journal of Medicine, vol. 357, no. 3, pp. 266–281, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. J. S. Adams, S.-Y. Ren, J. E. Arbelle et al., “Regulated production and intracrine action of 1,25-dihydroxyvitamin D3 in the chick myelomonocytic cell line HD-11,” Endocrinology, vol. 134, no. 6, pp. 2567–2573, 1994. View at Google Scholar · View at Scopus
  25. T. P. Jacobs and J. P. Bilezikian, “Clinical review: rare causes of hypercalcemia,” Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 11, pp. 6316–6322, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. F. W. Lafferty, “Differential diagnosis of hypercalcemia,” Journal of Bone and Mineral Research, vol. 6, supplement 2, pp. S51–S59, 1991. View at Google Scholar · View at Scopus
  27. E. Lebacq, V. Desmet, and H. Verhaegen, “Renal involvement in sarcoidosis,” Postgraduate Medical Journal, vol. 46, no. 538, pp. 526–529, 1970. View at Publisher · View at Google Scholar · View at Scopus
  28. K. W. Berger and A. S. Relman, “Renal impairment due to sarcoid infiltration of the kidney; report of a case proved by renal biopsies before and after treatment with cortisone,” The New England Journal of Medicine, vol. 252, p. 44, 1955. View at Google Scholar
  29. G. Rizzato, P. Fraioli, and L. Montemurro, “Nephrolithiasis as a presenting feature of chronic sarcoidosis,” Thorax, vol. 50, no. 5, pp. 555–559, 1995. View at Publisher · View at Google Scholar · View at Scopus
  30. C. A. Stuart, F. A. Neelon, and H. E. Lebovitz, “Disordered control of thirst in hypothalamic-pituitary sarcoidosis,” The New England Journal of Medicine, vol. 303, no. 19, pp. 1078–1082, 1980. View at Publisher · View at Google Scholar · View at Scopus
  31. D. R. J. Singer and D. J. Evans, “Renal impairment in sarcoidosis: granulomatous nephritis as an isolated cause (two case reports and review of the literature),” Clinical Nephrology, vol. 26, no. 5, pp. 250–256, 1986. View at Google Scholar · View at Scopus
  32. A. R. Berliner, M. Haas, and M. J. Choi, “Sarcoidosis: the Nephrologist's perspective,” American Journal of Kidney Diseases, vol. 48, no. 5, pp. 856–870, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Mahévas, F. X. Lescure, J.-J. Boffa et al., “Renal sarcoidosis: clinical, laboratory, and histologic presentation and utcome in 47 patients,” Medicine, vol. 88, no. 2, pp. 98–106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. B. J. Hunt and E. R. Yendt, “The response of hypercalcemia in sarcoidosis to chloroquine,” Annals of Internal Medicine, vol. 59, pp. 554–564, 1963. View at Publisher · View at Google Scholar · View at Scopus
  35. J. S. Adams, O. P. Sharma, M. M. Diz, and D. B. Endres, “Ketoconazole decreases the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia,” The Journal of Clinical Endocrinology & Metabolism, vol. 70, no. 4, pp. 1090–1095, 1990. View at Publisher · View at Google Scholar · View at Scopus